Searched for
U.S. INTERNAL REVENUE SERVICE
FIFA 2026 - How a warm World Cup welcome is endearing the US to fansInitial skepticism about the U.S. co-hosting the World Cup is giving way to positive experiences for international fans. Discoveries of Ame...- Yen nears 40-year low, dollar gains as peace talks in doubtThe US dollar is flexing its muscles against the Japanese yen, much to the attention of market traders. The potential for a US-Iran peace a...
- US-Iran peace talks in Geneva called off, clouding prospects for lasting truceTalks between the US and Iran to end the Middle East conflict have been postponed. Vice President JD Vance has cancelled his trip to Geneva...
- US Stock Market: Foreign investors add $103 billion to US long-term securities in AprilForeign investors showed strong interest in U.S. assets in April. They purchased $103 billion in long-term securities. Holdings of U.S. Tre...
- Pfizer CFO Dave Denton to leave company in AugustPfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...
- Hi(gh) Gasoline! US retail sales in May rise on auto powerAmerican shoppers spent more in May than anticipated. This boost came from tax refunds and a stock market rise. However, this spending has ...
- Gold recoups losses as oil prices fall on Iran dealGold prices saw a significant jump on Thursday, recovering from earlier declines. This surge followed a drop in oil prices. The United Stat...
- Gold falls 1% after Fed holds rates steady, signals rate hike this yearGold prices fell significantly on Wednesday. The U.S. Federal Reserve kept interest rates unchanged but indicated a possible increase later...
- Senior US officials release text of Iran dealA draft memorandum of understanding between the US and Iran has been revealed. It includes new standards for uranium enrichment and provisi...
- US quietly allows waiver on Russian oil to expireAmerica's Treasury has not extended sanctions waivers on Russian oil. This waiver expired at midnight. President Trump has not confirmed if...
- US holds off blacklisting China's DeepSeek, more than 100 firms deemed security risks, sources sayDeepSeek, CXMT and other companies were approved by an interagency committee last year for addition to the Commerce Department's Entity Lis...
- Gold edges up as rate-hike fears ease; Fed rate decision in focusGold prices are climbing for the fifth consecutive session. Optimism surrounding a U.S.-Iran peace deal is easing concerns about interest r...
- Self-driving tech supplier Mobileye plans US robotaxi service next yearMobileye will launch its own robotaxi service in the United States next year. The company plans to deploy about 100 robotaxis in a major US...
- Rupee inches up, Iran deal longevity worries and hedging dragThe Indian rupee saw a modest rise against the U.S. dollar, influenced by a U.S.-Iran truce but tempered by importer hedging and skepticism...
- US stocks: Aerospace parts maker Doncasters targets $4.4 billion valuation in US IPOAerospace innovator Doncasters is gearing up for a high-stakes debut in the U.S. public market, targeting an impressive $746.7 million by o...
- A history of Iran's nuclear programme and tensions with the US as an interim deal is reachedA landmark interim deal between the United States and Iran aims to end a protracted war and reopen the vital Strait of Hormuz. This agreeme...
- Trump names James McDonald as US attorney for ManhattanDonald Trump said he will appoint James McDonald, who previously served as an assistant U.S. attorney and CFTC enforcement chief.
- US stocks: Musk's SpaceX prices record $75 billion IPO at $135 a shareSpaceX has priced its record-breaking U.S. IPO at $135 per share, raising $75 billion and valuing the company at $1.77 trillion. This makes...
- Iran-U. S War: Washington, Tehran interim deal stalled over $6 billion to $12 billion of frozen funds? Read shocking reportU.S. President Donald Trump has repeatedly said a deal is close, while also threatening to intensify bombing.
- Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...
Load More
